A carregar...
Evaluating the Effect of the Changes in FDA Guidelines for Clozapine Monitoring
BACKGROUND: Concerns exist that clozapine is underutilized in the management of treatment-resistant schizophrenia. Although a 2015 change in the US Food and Drug Administration (FDA) monitoring recommendations lowered the threshold of the absolute neutrophil count for treatment interruption from 1,5...
Na minha lista:
| Publicado no: | J Clin Psychiatry |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5669833/ https://ncbi.nlm.nih.gov/pubmed/28742291 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/JCP.16m11152 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|